1. 107PPhase Ib/II study of biweekly TAS-102 with bevacizumab combination for patients with metastatic colorectal cancer refractory to standard therapies (BiTS study): Phase Ib results. (25th November 2018) Authors: Kagawa, Y; Satake, H; Kato, T; Oba, K; Yasui, H; Nakamura, M; Watanabe, T; Hirata, K; Muro, K; Komatsu, Y; Yoshino, T; Yamazaki, K; Mishima, H; Kotaka, M; Tsuji, A; Kakeji, Y; Oki, E; Nagata, N; Junichi, S Journal: Annals of oncology Issue: Volume 29(2018)Supplement 9 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. 465PTreatment pattern and outcomes of trifluridine/tipiracil therapy for metastatic colorectal cancer in the real-world data from the JFMC50 study. (23rd October 2018) Authors: Kawakami, T; Yamazaki, K; Oki, E; Shimokawa, M; Takahashi, N; Yokota, M; Tokunaga, S; Esaki, T; Gamoh, M; Maeda, A; Tsuji, Y; Sakai, A; Hatanaka, K; Shimada, Y; Shiozawa, M; Komatsu, Y; Okuda, H; Ohue, M; Maehara, Y Journal: Annals of oncology Issue: Volume 29(2018)Supplement 8 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. 488PHistopathologic evaluation of patients with liver-limited metastatic colorectal cancer receiving mFOLFOX6 plus bevacizumab or mFOLFOX6 plus cetuximab: The ATOM trial. (23rd October 2018) Authors: Emi, Y; Yamanaka, T; Muro, K; Uetake, H; Oki, E; Takahashi, T; Katayose, Y; Yoshida, K; Sakamoto, M; Aishima, S; Ishida, K; Imura, J; Unno, M; Hyodo, I; Tomita, N; Sugihara, K; Maehara, Y Journal: Annals of oncology Issue: Volume 29(2018)Supplement 8 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. 670PPhase II study of S-1 and oxaliplatin as neo-adjuvant chemotherapy for locally advanced gastric and esophago-gastric cancer (KSCC1601). (23rd October 2018) Authors: Kobayashi, K; Iwatsuki, M; Orita, H; Hidaka, S; Arigami, T; Kusumoto, T; Satake, H; Oki, E; Satoshi, K; Tobimatsu, K; Shimokawa, M; Saeki, H; Makiyama, A; Kakeji, Y; Natsugoe, S; Baba, H; Eguchi, S; Maehara, Y Journal: Annals of oncology Issue: Volume 29(2018)Supplement 8 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. Alteration in faecal bile acids, gut microbial composition and diversity after laparoscopic sleeve gastrectomy. Issue 12 (20th May 2020) Authors: Ikeda, T; Aida, M; Yoshida, Y; Matsumoto, S; Tanaka, M; Nakayama, J; Nagao, Y; Nakata, R; Oki, E; Akahoshi, T; Okano, S; Nomura, M; Hashizume, M; Maehara, Y Journal: British journal of surgery Issue: Volume 107:Issue 12(2020) Page Start: 1673 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. Efficacy of mizoribine-tacrolimus-based induction therapy for pediatric lupus nephritis. (July 2014) Authors: Tanaka, H; Aizawa, T; Watanabe, S; Oki, E; Tsuruga, K; Imaizumi, T Journal: Lupus Issue: Volume 23:Number 8(2014) Page Start: 813 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. O-005A multicentre, prospective clinical evaluation study for analyzing RAS mutational status utilizing plasma circulating tumor DNA in patients with metastatic colorectal cancer. (20th June 2018) Authors: Kagawa, Y; Kato, T; Bando, H; Akagi, K; Denda, T; Nishina, T; Komatsu, Y; Oki, E; Kudo, T; Yamanaka, T; Yoshino, T Journal: Annals of oncology Issue: Volume 29(2018)Supplement 5 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. O-017SUNRISE-DI study: decision impact of the 12-gene recurrence score (12-RS) assay on adjuvant chemotherapy recommendation for stage II and IIIA/B colon cancer. (2nd July 2019) Authors: Watanabe, J; Sato, T; Kagawa, Y; Oki, E; Kuboki, Y; Ikeda, M; Ueno, H; Kato, T; Kusumoto, T; Masuishi, T; Yamaguchi, K; Kanazawa, A; Nishina, T; Uetake, H; Yamanaka, T; Yoshino, T Journal: Annals of oncology Issue: Volume 30(2019)Supplement 4 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
9. P-034PARADIGM study: A multicenter, randomized, phase III study of mFOLFOX6 plus panitumumab or bevacizumab as first-line treatment in patients with RAS (KRAS/NRAS) wild-type metastatic colorectal cancer. (2nd July 2019) Authors: Muro, K; Uetake, H; Tsuchihara, K; Shitara, K; Yamazaki, K; Ota, M; Oki, E; Sato, T; Naitoh, T; Komatsu, Y; Kato, T; Yamanaka, K; Mori, I; Soeda, J; Hihara, M; Yamanaka, T; Akagi, K; Ochiai, A; Yoshino, T Journal: Annals of oncology Issue: Volume 30(2019)Supplement 4 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
10. P-253A phase I/II study of panitumumab combined with TAS-102 in patients (pts) with RAS wild-type (wt) metastatic colorectal cancer (mCRC) refractory to standard chemotherapy: APOLLON study. (20th June 2018) Authors: Yamazaki, K; Yasui, H; Yamaguchi, K; Kagawa, Y; Kuboki, Y; Yoshino, T; Gamoh, M; Komatsu, Y; Satake, H; Goto, M; Tanioka, H; Oki, E; Kotaka, M; Makiyama, A; Denda, T; Soeda, J; Shibya, K; Iwata, M; Oba, K; Kato, T Journal: Annals of oncology Issue: Volume 29(2018)Supplement 5 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗